2.0
22 Sept 2025
Current employee, more than 3 years
Dublin, Dublin
Recommend
CEO approval
Business outlook
Pros
Managers are generally nice. Solid entry point into Pharma Finance. Good exposure to different types of work.
Cons
Pay does not make sense in Dublin. Endless outsourcing to India with a drop in quality of work. Just look at the stock price. Company is losing clients and it does not look like a turnaround is in the cards. Merger between LPRA and ICON has been a disaster. It has left two companies weaker than either one was separate.